These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 27008594

  • 1. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
    Margonis GA, Samaha M, Kim Y, Postlewait LM, Kunz P, Maithel S, Tran T, Berger N, Gamblin TC, Mullen MG, Bauer TW, Pawlik TM.
    J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
    [Abstract] [Full Text] [Related]

  • 2. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T, Nara S, Kishi Y, Esaki M, Shimada K, Hiraoka N.
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [Abstract] [Full Text] [Related]

  • 3. Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum.
    Zhou B, Zhang M, Wu J, Yan S, Zhou J, Zheng S.
    World J Surg Oncol; 2013 Aug 14; 11():196. PubMed ID: 23945012
    [Abstract] [Full Text] [Related]

  • 4. Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.
    Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, Groeschl R, Hyder O, Kooby DA, Blazer D, Choti MA, Wolfgang CL, Gamblin TC, Hawkins WG, Maithel SK, Pawlik TM.
    Ann Surg Oncol; 2012 Oct 14; 19(11):3351-60. PubMed ID: 22878613
    [Abstract] [Full Text] [Related]

  • 5. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH.
    J Gastrointest Surg; 2014 Mar 14; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
    Dasari BVM, Al-Shakhshir S, Pawlik TM, Shah T, Marudanayagam R, Sutcliffe RP, Mirza DF, Muiesan P, Roberts KJ, Isaac J.
    J Gastrointest Surg; 2018 Sep 14; 22(9):1652-1658. PubMed ID: 29869091
    [Abstract] [Full Text] [Related]

  • 7. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R, Ponchon T, Napoleon B, Scoazec JY, Guillaud O, Saurin JC, Ciocirlan M, Lepilliez V, Pioche M, Lefort C, Adham M, Pialat J, Chayvialle JA, Walter T.
    Endoscopy; 2016 Nov 14; 48(11):979-986. PubMed ID: 27494453
    [Abstract] [Full Text] [Related]

  • 8. Surgery for Duodenal Gastrointestinal Stromal Tumors: A Single-Center Experience.
    Chen P, Song T, Wang X, Zhou H, Zhang T, Wu Q, Kong D, Cui Y, Li H, Li Q.
    Dig Dis Sci; 2017 Nov 14; 62(11):3167-3176. PubMed ID: 28914399
    [Abstract] [Full Text] [Related]

  • 9. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA.
    J Surg Oncol; 2021 Feb 14; 123(2):416-424. PubMed ID: 33125737
    [Abstract] [Full Text] [Related]

  • 10. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
    Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Spolverato G, Maithel SK, Pawlik TM.
    J Surg Oncol; 2020 Sep 14; 122(3):442-449. PubMed ID: 32470159
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
    Park SG, Lee BE, Kim GH, Park JW, Lee MW, Kim SJ, Choi CW, Lee S, Park DY.
    Medicine (Baltimore); 2019 Jun 14; 98(23):e15885. PubMed ID: 31169696
    [Abstract] [Full Text] [Related]

  • 12. Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results.
    Shamali A, McCrudden R, Bhandari P, Shek F, Barnett E, Bateman A, Abu Hilal M.
    Eur J Gastroenterol Hepatol; 2016 Dec 14; 28(12):1388-1393. PubMed ID: 27603299
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL, Zhang YQ, Chen WF, Xu MD, Zhong YS, Ma LL, Qin WZ, Hu JW, Cai MY, Yao LQ, Zhou PH.
    World J Gastroenterol; 2012 Oct 28; 18(40):5799-806. PubMed ID: 23155323
    [Abstract] [Full Text] [Related]

  • 14. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC, Liu Y, Lee RM, Zaidi MY, Staley CA, Kooby DA, Winer JH, Shah MM, Russell MC, Cardona K, Maithel SK.
    J Surg Oncol; 2019 Dec 28; 120(8):1293-1301. PubMed ID: 31621090
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ, Hong SJ, Han JP, Kim HS, Jeong GA, Cho GS, Kim HK, Ko BM, Lee MS.
    J Dig Dis; 2015 Oct 28; 16(10):595-600. PubMed ID: 26315879
    [Abstract] [Full Text] [Related]

  • 16. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T, Denbo J, Sharpe J, Martin M, O'Brien T, Gupta R, Groshart K, Behrman S, Dickson P.
    World J Surg; 2017 Mar 28; 41(3):844-850. PubMed ID: 27743074
    [Abstract] [Full Text] [Related]

  • 17. Duodenal Neuroendocrine Tumors: Location Matters!
    Sheikh MR, Osman H, Cheek S, Hunter S, Jeyarajah DR.
    Am Surg; 2016 May 28; 82(5):386-9. PubMed ID: 27215716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
    Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S.
    Ann Surg Oncol; 2018 Feb 28; 25(2):528-534. PubMed ID: 29164413
    [Abstract] [Full Text] [Related]

  • 20. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A, Bergmann F, Hinz U, Schimmack S, Hackert T, Büchler MW, Strobel O.
    Eur J Surg Oncol; 2020 Jun 28; 46(6):1088-1096. PubMed ID: 32088004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.